Canopy Growth Corp
Business
Canopy Growth Corp produces, distributes and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes. Its product offerings include high-quality dried flower, pre-rolled joints, oils, softgel capsules, edibles (including gummies), extracts and industry-leading vaporizer devices and accessories. The company reports results across four reportable segments: Canada cannabis, International markets cannabis, Storz & Bickel (vaporizer devices), and formerly This Works (wellness products). It operates principally in Canada, Germany and Australia, sells medical products direct-to-patient via e-commerce and supplies adult-use products through provincial/territorial retail distribution systems, and holds a non-controlling interest in Canopy USA for U.S. market exposure.
Summary from filing dated 2025-05-30
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-03-31 | FY 2024 2024-03-31 | FY 2023 2023-03-31 | FY 2022 2022-03-31 | FY 2021 2021-03-31 |
|---|---|---|---|---|---|---|
| Revenue | 314 | 344 | 381 | 538 | 607 | |
| Excise taxes | 45 | 47 | 48 | 62 | 61 | |
| Net revenue | 269 | 297 | 333 | 476 | 547 | |
| Cost of goods sold | 189 | 216 | 397 | 663 | 480 | |
| Gross margin | 80 | 81 | −64 | −187 | 67 | |
| Selling, general and administrative expenses | 170 | 229 | 343 | 415 | 575 | |
| Share-based compensation | −4 | 14 | 25 | 47 | 91 | |
| Loss on asset impairment and restructuring | 31 | 66 | 2,199 | 369 | — | |
| Total operating expenses | 197 | 310 | 2,567 | 831 | 1,310 | |
| Operating loss from continuing operations | −117 | −229 | −2,631 | −1,019 | −1,243 | |
| Other income (expense), net | −480 | −243 | −456 | 751 | −388 | |
| Loss from continuing operations before income taxes | −597 | −471 | −3,086 | −268 | −1,684 | |
| Income tax (expense) recovery | −7 | −12 | 6 | 9 | 13 | |
| Net loss from continuing operations | −604 | −484 | −3,080 | −259 | — | |
| Discontinued operations, net of income tax | 6 | −192 | −229 | −72 | — | |
| Net loss | −598 | −676 | −3,310 | −331 | −1,671 | |
| Net loss from continuing operations attributable to noncontrolling interests and redeemable noncontrolling interest | — | — | −2 | −4 | 74 | |
| Net loss from discontinued operations attributable to noncontrolling interests and redeemable noncontrolling interest | — | −19 | −29 | −16 | — | |
| Net loss attributable to Canopy Growth Corporation | −598 | −657 | −3,278 | −310 | −1,745 | |
| Basic loss per share continuing operations | −5.62 | −6.47 | −66.39 | −6.5 | — | |
| Diluted loss per share continuing operations | −5.62 | −6.47 | −66.39 | −6.5 | — | |
| Basic loss per share discontinued operations | 0.06 | −2.32 | −4.3 | −1.42 | — | |
| Diluted loss per share discontinued operations | 0.06 | −2.32 | −4.3 | −1.42 | — | |
| Basic loss per share | −5.56 | −8.79 | −70.69 | −7.92 | −4.69 | |
| Diluted loss per share | −5.56 | −8.79 | −70.69 | −7.92 | −4.69 | |
| Basic weighted average common shares outstanding | 108 | 75 | 46 | 39 | 372 | |
| Diluted weighted average common shares outstanding | 108 | 75 | 46 | 39 | 372 | |
| Fair value changes of own credit risk of financial liabilities | 0 | −12 | 31 | 21 | −100 | |
| Foreign currency translation | 13 | −917,000 | 27 | −45 | −155 | |
| Total other comprehensive income (loss), net of income tax | 13 | −13 | 58 | −24 | −255 | |
| Comprehensive loss from continuing operations | −591 | −497 | −3,023 | −283 | — | |
| Comprehensive income (loss) from discontinued operations | 6 | −192 | −229 | −72 | — | |
| Comprehensive loss | −585 | −689 | −3,252 | −355 | −1,926 | |
| Comprehensive loss from continuing operations attributable to noncontrolling interests and redeemable noncontrolling interest | — | — | −2 | −4 | — | |
| Comprehensive loss from discontinued operations attributable to noncontrolling interests and redeemable noncontrolling interest | — | −19 | −29 | −16 | — | |
| Comprehensive loss attributable to Canopy Growth Corporation | −585 | −671 | −3,220 | −334 | −2,000 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-03-31 | FY 2024 2024-03-31 | FY 2023 2023-03-31 | FY 2022 2022-12-31 | FY 2022 2022-09-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 114 | 170 | 668 | — | — | |
| Short-term investments | 18 | 33 | 106 | — | — | |
| Restricted short-term investments | 6 | 7 | 12 | — | — | |
| Amounts receivable, net | 53 | 52 | 68 | 82 | 82 | |
| Inventory | 96 | 77 | 83 | 214 | 212 | |
| Assets of discontinued operations | 0 | 8 | 116 | — | — | |
| Prepaid expenses and other assets | 8 | 23 | 24 | 52 | 63 | |
| Total current assets | 295 | 371 | 1,077 | 1,150 | 1,513 | |
| Other investments | 180 | 438 | — | — | — | |
| Property, plant and equipment | 294 | 320 | 471 | — | — | |
| Intangible assets | 87 | 104 | 161 | — | — | |
| Goodwill | 46 | 43 | 86 | 85 | 79 | |
| Other assets | 16 | 24 | 20 | — | — | |
| Total assets | 918 | 1,300 | 2,440 | 2,939 | 3,319 | |
| Accounts payable | 26 | 29 | 32 | — | — | |
| Other accrued expenses and liabilities | 39 | 54 | 54 | — | — | |
| Current portion of long-term debt | 4 | 104 | 557 | — | — | |
| Other liabilities | 25 | 48 | 94 | 85 | 80 | |
| Total current liabilities | 94 | 235 | 804 | 679 | 559 | |
| Long-term debt | 300 | 493 | 750 | — | — | |
| Other liabilities | 36 | 72 | 122 | — | — | |
| Total liabilities | 430 | 800 | 1,680 | 1,581 | 1,754 | |
| Commitments and contingencies | — | — | — | — | — | |
| Common shares - $nil par value; Authorized - unlimited; Issued and outstanding - 183,865,295 shares and 91,115,501 shares, respectively. Exchangeable shares - $nil par value; Authorized - unlimited; Issued and outstanding - 26,261,474 shares and nil shares, respectively. | 8,796 | 8,244 | 7,939 | — | — | |
| Additional paid-in capital | 2,618 | 2,602 | 2,506 | 2,534 | 2,538 | |
| Accumulated other comprehensive loss | 535,000 | −16 | −14 | — | — | |
| Deficit | −10,928 | −10,330 | −9,673 | −9,033 | −8,773 | |
| Total Canopy Growth Corporation shareholders' equity | 487 | 500 | 758 | 1,355 | 1,549 | |
| Noncontrolling interests | 0 | 139,000 | 2 | — | — | |
| Total shareholders' equity | 487 | 501 | 760 | 1,358 | 1,552 | |
| Total liabilities and shareholders' equity | 918 | 1,300 | 2,440 | 2,939 | 3,319 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-03-31 | FY 2024 2024-03-31 | FY 2023 2023-03-31 | FY 2022 2022-03-31 | FY 2021 2021-03-31 |
|---|---|---|---|---|---|---|
| Depreciation of property, plant and equipment | 22 | 28 | 56 | 76 | 71 | |
| Amortization of intangible assets | 22 | 25 | 24 | 35 | 56 | |
| Share-based compensation | −4 | 14 | 25 | 47 | 91 | |
| Loss on asset impairment and restructuring | 20 | 54 | 2,171 | 333 | — | |
| Non-cash fair value adjustments and charges related to settlement of long-term debt | 413 | 160 | 354 | — | — | |
| Amounts receivable | −4 | −4 | 6 | 16 | −12 | |
| Inventory | −18 | 1 | 68 | 204 | 23 | |
| Prepaid expenses and other assets | 6 | −2 | 13 | 28 | 77,000 | |
| Accounts payable and accrued liabilities | −15 | 9 | −28 | −43 | 17 | |
| Other, including non-cash foreign currency | −9 | −43 | 3 | −7 | −90 | |
| Net cash used in operating activities - continuing operations | −166 | −228 | −394 | −446 | — | |
| Net cash used in operating activities - discontinued operations | — | −54 | −163 | −100 | — | |
| Net cash used in operating activities | −166 | −282 | −558 | −546 | −466 | |
| Purchases of and deposits on property, plant and equipment | −11 | −3 | −9 | −37 | −165 | |
| Purchases of intangible assets | −467,000 | −547,000 | −1 | −11 | −10 | |
| Proceeds on sale of property, plant and equipment | 5 | 154 | 14 | 27 | 46 | |
| Redemption of short-term investments | 16 | 79 | 503 | 546 | −460 | |
| Net cash (outflow) inflow on sale or deconsolidation of subsidiaries | −7 | −955,000 | 15 | — | — | |
| Net cash inflow on loan receivable | 30 | — | — | — | — | |
| Investment in other financial assets | −95 | −347,000 | −67 | −379 | −45 | |
| Other investing activities | — | −8 | 4 | −18 | −7 | |
| Net cash (used in) provided by investing activities - continuing operations | −62 | 220 | 457 | 231 | — | |
| Net cash provided by (used in) investing activities - discontinued operations | 14 | 22 | −24 | −19,000 | — | |
| Net cash (used in) provided by investing activities | −48 | 242 | 433 | 231 | −884 | |
| Proceeds from issuance of common shares and warrants | 385 | 81 | 1 | 3 | 0 | |
| Proceeds from exercise of stock options | 112,000 | — | 281,000 | 6 | 157 | |
| Proceeds from exercise of warrants | 8 | — | — | 0 | 245 | |
| Issuance of long-term debt and convertible debentures | 68 | — | 135 | 0 | 893 | |
| Repayment of long-term debt | −100 | −510 | −118 | −51 | −16 | |
| Other financing activities | −25 | −36 | −38 | −3 | −15 | |
| Net cash provided by (used in) financing activities | 149 | −465 | −20 | −46 | 1,265 | |
| Effect of exchange rate changes on cash and cash equivalents | 8 | −1 | 45 | −18 | −63 | |
| Net decrease in cash and cash equivalents | −56 | −507 | −99 | −379 | −149 | |
| Income taxes | 128,000 | 6 | 6 | 1 | 4 | |
| Interest | 9 | 18 | 29 | 16 | 26 | |
| Income taxes | 783,000 | 2 | 1 | 3 | 23 | |
| Interest | 65 | 98 | 132 | 119 | 26 | |
| Additions to property, plant and equipment | 426,000 | 106,000 | 38,000 | 1 | 10 |